Barbara Cellini serves as an Assistant Professor of biochemistry at the University of Verona, Verona, Italy. She received the degree in biological sciences (biomolecular sector), summa cum laude, at the University of Urbino, Italy in 2000 and the Ph.D. degree in biochemistry at the University of Verona in 2005. In July 2010, September 2010, and April 2011 she has been a Visiting Scientist at the Department of Cell and Developmental Biology of the University College London, UK under the supervision of Prof. C. J. Danpure. The research activity of Dr. Cellini is mainly focused on the study of the molecular bases of diseases involving two pyridoxal 5’-phosphate-dependent enzymes: liver peroxisomal alanine: glyoxylate aminotransferase, an enzyme whose deficiency causes primary hyperoxaluria type I, and Dopa decarboxylase, the target for the treatment of Parkinson disease and involved in a neurometabolic disorder caused by the deficiency of the enzyme. The scientific activity of Dr. Cellini is documented from invitations to national, international meetings, and from 30 papers published on journals with medium-high impact factor. She serves as a Reviewer for journals in the biochemistry field, such as Biochemical Journal, Biochimie, International Journal of Peptide Research and Therapeutics, Therapeutics and Clinical Risk Management, and Acta Hystochemistry and Cytochemistry.
Biography Updated on 13 November 2012